Liontrust Investment Partners LLP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
Liontrust Investment Partners LLP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,075,280
-16.7%
421,000
-5.7%
0.06%
-18.1%
Q1 2023$4,893,640
+153.7%
446,5000.0%0.07%
+111.8%
Q4 2022$1,928,880
-99.9%
446,5000.0%0.03%
-37.0%
Q3 2022$3,357,680,000
-25.2%
446,5000.0%0.05%
-14.3%
Q2 2022$4,487,325,000
-18.8%
446,5000.0%0.06%
-12.5%
Q1 2022$5,527,670,000
-45.9%
446,5000.0%0.07%
-40.5%
Q4 2021$10,211,455,000446,5000.12%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders